BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 12368300)

  • 41. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages.
    Liou LY; Haaland RE; Herrmann CH; Rice AP
    J Leukoc Biol; 2006 Feb; 79(2):388-96. PubMed ID: 16330531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA.
    Garber ME; Wei P; Jones KA
    Cold Spring Harb Symp Quant Biol; 1998; 63():371-80. PubMed ID: 10384302
    [No Abstract]   [Full Text] [Related]  

  • 43. Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat.
    Jadlowsky JK; Nojima M; Okamoto T; Fujinaga K
    J Gen Virol; 2008 Nov; 89(Pt 11):2783-2787. PubMed ID: 18931076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
    Sun J; Soos T; Kewalramani VN; Osiecki K; Zheng JH; Falkin L; Santambrogio L; Littman DR; Goldstein H
    J Virol; 2006 Feb; 80(4):1850-62. PubMed ID: 16439541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.
    Wei P; Garber ME; Fang SM; Fischer WH; Jones KA
    Cell; 1998 Feb; 92(4):451-62. PubMed ID: 9491887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.
    Wang Q; Young TM; Mathews MB; Pe'ery T
    J Mol Biol; 2007 Mar; 367(3):630-46. PubMed ID: 17289077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription.
    Chen D; Fong Y; Zhou Q
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2728-33. PubMed ID: 10077579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.
    Jadlowsky JK; Nojima M; Schulte A; Geyer M; Okamoto T; Fujinaga K
    Retrovirology; 2008 Jul; 5():63. PubMed ID: 18620576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex.
    D'Orso I; Frankel AD
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3101-6. PubMed ID: 19223581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation.
    Kwak YT; Ivanov D; Guo J; Nee E; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):57-69. PubMed ID: 10329126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
    Gao G; Wu X; Zhou J; He M; He JJ; Guo D
    J Biol Chem; 2013 May; 288(20):14297-14309. PubMed ID: 23569210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
    Zhu Y; Pe'ery T; Peng J; Ramanathan Y; Marshall N; Marshall T; Amendt B; Mathews MB; Price DH
    Genes Dev; 1997 Oct; 11(20):2622-32. PubMed ID: 9334325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    EMBO J; 1998 Dec; 17(23):7056-65. PubMed ID: 9843510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1.
    Das C; Edgcomb SP; Peteranderl R; Chen L; Frankel AD
    Virology; 2004 Jan; 318(1):306-17. PubMed ID: 14972556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
    Kanazawa S; Okamoto T; Peterlin BM
    Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs.
    Yu W; Wang Y; Shaw CA; Qin XF; Rice AP
    Retrovirology; 2006 Jun; 3():32. PubMed ID: 16764723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.